The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

CHEMBL1367     2-propylpent-4-enoic acid

Synonyms: R,S-4-en-VPA, AG-E-06577, AC1L2XON, CTK4C9400, AR-1E5224, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of 2-Allylpentanoic acid

  • Increased values of 2-n-propyl-4-pentenoic acid metabolite of VPA (4-ene-VPA), could be detected only in 1 of the 5 patients with fulminant liver failure and in one other child with a slight hepatic dysfunction, indicating that this VPA metabolite is not the decisive hepatotoxin or indicator of hepatotoxicity [1].
 

High impact information on 2-Allylpentanoic acid

 

Biological context of 2-Allylpentanoic acid

References

  1. Valproate (VPA) metabolites in various clinical conditions of probable VPA-associated hepatotoxicity. Siemes, H., Nau, H., Schultze, K., Wittfoht, W., Drews, E., Penzien, J., Seidel, U. Epilepsia (1993) [Pubmed]
  2. Cytochrome P-450-catalyzed desaturation of valproic acid in vitro. Species differences, induction effects, and mechanistic studies. Rettie, A.E., Boberg, M., Rettenmeier, A.W., Baillie, T.A. J. Biol. Chem. (1988) [Pubmed]
  3. Effects of polytherapy with phenytoin, carbamazepine, and stiripentol on formation of 4-ene-valproate, a hepatotoxic metabolite of valproic acid. Levy, R.H., Rettenmeier, A.W., Anderson, G.D., Wilensky, A.J., Friel, P.N., Baillie, T.A., Acheampong, A., Tor, J., Guyot, M., Loiseau, P. Clin. Pharmacol. Ther. (1990) [Pubmed]
  4. A comparative investigation of 2-propyl-4-pentenoic acid (4-ene VPA) and its alpha-fluorinated analogue: phase II metabolism and pharmacokinetics. Tang, W., Abbott, F.S. Drug Metab. Dispos. (1997) [Pubmed]
  5. Characterization of thiol-conjugated metabolites of 2-propylpent-4-enoic acid (4-ene VPA), a toxic metabolite of valproic acid, by electrospray tandem mass spectrometry. Tang, W., Abbott, F.S. Journal of mass spectrometry : JMS. (1996) [Pubmed]
  6. Pharmacokinetics and enterohepatic circulation of 2-n-propyl-4-pentenoic acid in the rat. Singh, K., Orr, J.M., Abbott, F.S. Drug Metab. Dispos. (1988) [Pubmed]
  7. Studies on the biotransformation in the perfused rat liver of 2-n-propyl-4-pentenoic acid, a metabolite of the antiepileptic drug valproic acid. Evidence for the formation of chemically reactive intermediates. Rettenmeier, A.W., Prickett, K.S., Gordon, W.P., Bjorge, S.M., Chang, S.L., Levy, R.H., Baillie, T.A. Drug Metab. Dispos. (1985) [Pubmed]
 
WikiGenes - Universities